Oireachtas Joint and Select Committees

Wednesday, 21 November 2018

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion (Resumed)

See the whole debate « Previous speaker Next speaker »

9:00 am

Mr. Shaun Flanagan:

As far as I am aware, there will not be a market authorisation in Europe for cervical cancer for pembrolizumab or any other immunotherapy before 2021 at the earliest.

Comments

No comments

 

Log in or join to post a public comment.